ArticleNeuro-oncology advances

Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPG.

Christopher L Tinkle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.